UiPath (NYSE:PATH) Price Target Raised to $18.00

UiPath (NYSE:PATH – Free Report) had its price target increased by Bank of America from $16.00 to $18.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a neutral rating on the healthcare company’s stock. A number of other brokerages have also recently weighed in on PATH. DA Davidson dropped […]

Leave a Reply

Your email address will not be published.

Previous post Capital One Financial Co. (NYSE:COF) Receives $145.89 Average Price Target from Analysts
Next post Monolithic Power Systems, Inc. (NASDAQ:MPWR) Given Average Rating of “Buy” by Brokerages